MordenNEChangCHJacobsonJO. End-of-life care for medicare beneficiaries with cancer is highly intensive overall and varies widely. Health Affairs2012;4:786–796.
Level I Pathways. The US Oncology Network Web site. Available at: http://www.usoncology.com/cancercareadvocates/AdvancingCancerCare/DeliverHigh-QualityCare/LevelIPathways. Accessed July 27 2012.
FeinbergBALangJGrzegorczykJ. Implementation of cancer clinical pathways: a successful model of collaboration between payers and providers. Am J Manag Care2012;18:e194–e199.
NeubauerMAHovermanJRKolodziejM. Cost effectiveness of evidence-based treatment guidelines for the treatment of non-small-cell lung cancer in the community setting. J Oncol Pract2010;6:12–18.
HovermanJRCartwrightTHPattDA. Pathways, outcomes, and costs in colon cancer: retrospective evaluations in two distinct databases. J Oncol Pract2011;7(3 Suppl):52S–59S.